當前位置：廈門慧嘉生物科技有限公司>>細胞因子>>Prospec >>VEGI Human/ 重組人血管內皮細胞生長抑制因子

VEGI Human/ 重組人血管內皮細胞生長抑制因子

返回列表頁

參考價

面議

具體成交價以合同協(xié)議為準

產(chǎn)品型號

品牌

廠商性質代理商

所在地廈門市

在線詢價收藏產(chǎn)品查看聯(lián)系電話

聯(lián)系方式：陳先生查看聯(lián)系方式

更新時間：2016-02-21 02:58:37瀏覽次數(shù)：215次

聯(lián)系我時，請告知來自環(huán)保在線

產(chǎn)品分類 品牌分類

  細胞因子

Prospec

全部產(chǎn)品列表

暫無信息

廈門慧嘉生物科技有限公司

經(jīng)營模式：代理商

商鋪產(chǎn)品：9325條

所在地區(qū)：福建廈門市

聯(lián)系人：陳先生

詢價 給他留言

產(chǎn)品簡介

VEGI Human/ 重組人血管內皮細胞生長抑制因子產(chǎn)品編號：CYT-517
產(chǎn)品規(guī)格：2μg/10μg/0.1mg

詳細介紹

VEGI Human/ 重組人血管內皮細胞生長抑制因子

產(chǎn)品編號：CYT-517
產(chǎn)品規(guī)格：2μg/10μg/0.1mg

Synonyms	Tumor necrosis factor ligand superfamily member 15, TNFSF-15, TNFSF15, TNF ligand-related molecule 1, VEGI, TL-1, TL1, TL1A, VEGI192A, VEGI-192, MGC129934, MGC129935.
Introduction	TNFSF15 is a cytokine that belongs to the tumor necrosis factor （TNF） ligand family. This protein is abundantly expressed in endothelial cells, but is not expressed in either B or T cells. The expression of TNFSF15 is inducible by TNF and IL-1 alpha. This cytokine is a ligand for receptor TNFRSF25 and decoy receptor TNFRSF21/DR6. It can activate NF-kappaB and MAP kinases, and acts as an autocrine factor to induce apoptosis in endothelial cells. TNFSF15 is also found to inhibit endothelial cell proliferation, and thus may function as an angiogenesis inhibitor. An additional isoform encoded by an alternatively spliced transcript variant has been reported but the sequence of this transcript has not been determined.
Description	TNFSF15 Human Recombinant produced in E.Coli is a double, non-glycosylated, polypeptide chain containing 192 amino acids and having a molecular mass of 21.8 kDa. The TNFSF15 is purified by proprietary chromatographic techniques.
Source	Escherichia Coli.
Physical Appearance	Sterile Filtered White lyophilized （freeze-dried） powder.
Formulation	The TNFSF15 was lyophilized from a concentrated （1 mg/ml） solution containing 0.5M NaCl and 50mM Tris-HCl pH-7.5.
Solubility	It is recommended to reconstitute the lyophilized TNFSF15 in sterile 18MΩ-cm H2O not less than 100 μg/ml, which can then be further diluted to other aqueous solutions.
Stability	TNFSF15 although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution VEGI should be stored at 4°C between 2-7 days and for future use below -18°C. For long term storage it is recommended to add a carrier protein （0.1% HSA or BSA）. Please prevent freeze-thaw cycles.
Purity	Greater than 95.0% as determined by（a） Analysis by RP-HPLC. （b） Analysis by SDS-PAGE.
Amino acid sequence	The sequence of the first five N-terminal amino acids was determined and was found to be Met-Gln-Leu-Thr-Lys.
Biological Activity	The ED50 as determined by the dose-dependant inhibition of the proliferation of HUVEC （Human Umbilical Vein Endothelial Cells） is less then 5μg/ml.
Usage	Prospec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.